July 4, 2015
Potential treatment could reduce relapses and disability progression
- /
Pharmaceutical company Roche has announced the completion two phase 3 trials (OPERA I and OPERA II), testing ocrelizumab in people with relapsing…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
July 4, 2015
Biogen Opens Gene Therapy Partnership
- /
- /
- /
July 2, 2015 iogen Inc. will broaden its gene therapy pipeline by signing a partnership with Applied Genetic Technologies Corp.…
July 4, 2015
Short Documentary on Multiple Sclerosis, Inspires
- /
2015-07-02 12:53 A 20-minute documentary (with English Sub-Titles) on multiple sclerosis, entitled simply “SM” (the original title in Polish) offers…
July 2, 2015
Lifestyle Changes Can HELP-to Heal Multiple Sclerosis
- /
- /
By Vera Tweed | Tuesday, 30 Jun 2015 Therapeutic lifestyle changes have recently become a top priority in multiple sclerosis research, and…
July 1, 2015
Genentech’s ocrelizumab Significantly Reduced Both Relapses and Disability Progression versus interferon beta-1a (Rebif®) in Two Phase III Studies in Multiple Sclerosis
- /
- /
June 30, 2015 Studies showed superiority on primary and major secondary endpoints in people with relapsing forms of multiple sclerosis Genentech…
July 1, 2015
Hadassah Conducts Unprecedented Trial of Stem Cell Treatment for MS
- /
- /
June 25, 2015 Prof. Dimitrios Karussis, head of Hadassah Medical Organization’s Multiple Sclerosis Center An unprecedented clinical trial launched at…
June 30, 2015
The Burden of Disease A closer look at the consequences of living with multiple sclerosis
- /
Click to open this .pdf document which will provide you with lots of information concerning the title of this posting…
June 30, 2015
Dear Dealing with Cabin Fever, have you considered arts and crafts?
- /
Dear Nurse, I’ve been out of work for two months now due to my latest flare. I lost my job…
June 29, 2015
Novartis’ Gilenya Found to Have Long-Term Positive Effects on Patients with Relapsing-Remitting Multiple Sclerosis
- /
A new study recently published in the Journal of Neurology, Neurosurgery and Psychiatryrevealed that long-term fingolimod therapy (marketed as Gilenya by Novartis) can maintain a…
June 29, 2015
SHARED SOLUTIONS® – offering many services for the MS Patient
- /
SHARED SOLUTIONS® Support and partnership you can trust Managing relapsing MS begins with living a healthy lifestyle and committing to a therapy…
